A blood transfusion center in a third world country are keen to reduce the incidence of post transfusion hepatitis C in their blood products.
on Friday, April 22, 2011
 Question Number 0108 Question: A blood transfusion center in a third world country are keen to reduce the incidence of post transfusion hepatitis C in their blood products. Which measure is most likely to reduce the incidence of posttransfusion hepatitis C in this center? a) hepatitis B immune globulin (HBIG) b) hepatitis B virus DNA c) hepatitis B e antigen d) hepatitis A e) atopic dermatitis
|
Labels: MRCP Part 1 MCQ, USMLE 01